Loading...
XHKG
1312
Market cap23mUSD
Oct 09, Last price  
0.03HKD
1D
0.00%
1Q
17.86%
Jan 2017
-95.15%
IPO
-84.72%
Name

Kontafarma China Holdings Ltd

Chart & performance

D1W1MN
XHKG:1312 chart
P/E
—
P/S
0.20
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-1.95%
Revenues
915m
+1.92%
451,444,000725,298,000704,698,000703,468,000733,125,000465,739,000633,279,0001,344,336,0002,093,724,0001,482,347,0001,009,134,000803,267,000894,062,000809,107,000897,521,000914,709,000
Net income
-428m
L+466.41%
168,332,00076,158,00026,834,00032,564,00017,280,000-34,237,000-37,076,000-1,806,00032,499,00065,211,000-267,164,000-15,048,000-41,546,000-28,843,000-75,537,000-427,848,000
CFO
77m
+62.98%
115,805,000-7,609,00045,311,000-64,462,000-8,130,000-14,735,00012,432,000-47,262,00066,864,00025,670,000206,933,00075,068,000-2,165,00037,119,00047,046,00076,676,000
Dividend
May 27, 20130.02 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Kontafarma China Holdings Ltd. directs its business efforts through two principal segments: Pharmaceutical and Fitness. Its Pharmaceutical arm is responsible for the manufacturing and marketing of prescription medications and associated laboratory goods. Meanwhile, the Fitness division oversees the management of health clubs, delivers advisory services for physical well-being and health-related pursuits, and runs a franchise model to generate royalty revenue. Established on March 21, 2011, the company maintains its corporate headquarters in Hong Kong.

Key people

Feifei Wang
Executive Chairman of the Board, President · since 2024
Jie Zhang
Chief Operating Officer · since 2024
Zixiu Guo
Financial Controller, Executive Director · since 2024
Jiankun Liu
Executive Director · since 2024
Linna Qiao
Vice President, Executive Director · since 2024
Lok Tung Chan
Company Secretary · since 2024
Yu Huang
Non-Executive Director · since 2024
Ho Ming Ho
Independent Non-Executive Director · since 2024
Lai Wah Tang
Independent Non-Executive Director · since 2024
Xiaomin Yao
Independent Non-Executive Director · since 2024
URL
http://www.kontafarma.com.hk/
IPO date
Jan 18, 2012
Employees
715
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT